Quest Investment Management LLC Has $1.58 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Quest Investment Management LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 9.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,921 shares of the company’s stock after selling 487 shares during the period. Quest Investment Management LLC’s holdings in HCA Healthcare were worth $1,581,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Gladstone Institutional Advisory LLC bought a new stake in HCA Healthcare in the 4th quarter valued at $200,000. Corient Private Wealth LLC grew its stake in HCA Healthcare by 22.8% in the 4th quarter. Corient Private Wealth LLC now owns 43,140 shares of the company’s stock valued at $11,677,000 after buying an additional 8,005 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of HCA Healthcare by 27.6% during the fourth quarter. Assetmark Inc. now owns 1,495 shares of the company’s stock worth $405,000 after acquiring an additional 323 shares during the period. Commerce Bank lifted its holdings in HCA Healthcare by 31.9% during the 4th quarter. Commerce Bank now owns 11,007 shares of the company’s stock worth $2,979,000 after purchasing an additional 2,660 shares during the last quarter. Finally, FineMark National Bank & Trust acquired a new position in HCA Healthcare in the 4th quarter valued at $973,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.3 %

Shares of NYSE HCA opened at $404.66 on Friday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $405.70. The stock has a market cap of $105.99 billion, a P/E ratio of 20.17, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The firm has a 50 day moving average price of $370.57 and a two-hundred day moving average price of $340.65.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the prior year, the firm posted $4.29 earnings per share. The business’s quarterly revenue was up 10.3% on a year-over-year basis. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at $3,436,623.54. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on HCA. Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Royal Bank of Canada raised their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Monday, August 19th. Finally, Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.